Andrew Callos - Mar 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: EVP, Chief Commercial Officer
Signature: /s/ John Faurescu, attorney-in-fact for Mr. Callos
Stock symbol: CYTK
Transactions as of: Mar 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/7/2023, 03:13 PM
Previous filing: Mar 3, 2023
Next filing: Mar 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Award	$0	+30K	+126.67%	$0.00	53.7K	Mar 6, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Incentive Stock Option (Right to Buy)	Award	$0	+2.56K		$0.00	2.56K	Mar 6, 2023	Common Stock	2.56K	$39.13	Direct	F2
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Award	$0	+47.4K		$0.00	47.4K	Mar 6, 2023	Common Stock	47.4K	$39.13	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2	This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.